Allogene Therapeutics, Inc.
ALLO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737287
In the last 90 days, Allogene Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 209 institutions reported holding it in 13F filings for Q2 2026, worth $652.0M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Allogene Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 180
- +3 vs. Q4 2021
- Shares held
- 91.7M
- +5.93M (+6.9%) vs. Q4 2021
- Total value
- $836.7M
- −$443.9M (−34.7%) vs. Q4 2021
- New holders
- 33
- 72 more added
- Sold out
- 30
- 45 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALLO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 209 | $652.0M |
| Q1 2026 | 209 | $444.7M |
| Q4 2025 | 172 | $222.7M |
| Q3 2025 | 170 | $201.0M |
| Q2 2025 | 158 | $207.9M |
| Q1 2025 | 171 | $288.5M |
| Q4 2024 | 174 | $401.9M |
| Q3 2024 | 156 | $460.4M |
| Q2 2024 | 175 | $385.1M |
| Q1 2024 | 161 | $586.0M |
| Q4 2023 | 170 | $392.4M |
| Q3 2023 | 155 | $413.3M |
| Q2 2023 | 171 | $662.9M |
| Q1 2023 | 176 | $582.3M |
| Q4 2022 | 168 | $700.9M |
| Q3 2022 | 192 | $1.15B |
| Q2 2022 | 161 | $1.15B |
| Q1 2022 | 180 | $836.7M |
| Q4 2021 | 177 | $1.28B |
| Q3 2021 | 169 | $2.26B |
| Q2 2021 | 182 | $2.25B |
| Q1 2021 | 169 | $3.12B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Allogene Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 0 | $0 | 0.00% | −10,675−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −6,605−100.0% | Sold out |
| Front Row Advisors LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −383−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −230−100.0% | Sold out |
| Eagle Bay Advisors LLC | 0 | $0 | 0.00% | −108−100.0% | Sold out |
| Umb Bank N A | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Lee Financial Co | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −15−100.0% | Sold out |